R. Townsend
Chief Executive Officer at LEXEO THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
R.
Nolan Townsend is currently the Chief Executive Officer & Director at Lexeo Therapeutics, Inc., the Director at Biotechnology Innovation Organization, and the Director at Arbor Biotechnologies, Inc. Previously, he served as the Chairman at Life Science Cares New York from 2022 to 2024 and as a Principal at Pfizer Inc. from 2008 to 2020.
He completed his undergraduate degree at the University of Pennsylvania in 2002 and earned an MBA from Harvard Business School in 2007.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEXEO THERAPEUTICS, INC.
0.64% | 2024-05-12 | 170,695 ( 0.64% ) | 2 M $ | 2024-04-29 |
R. Townsend active positions
| Companies | Position | Start |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Chief Executive Officer | 2019-12-31 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 2023-09-30 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 2023-09-30 |
Former positions of R. Townsend
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 2019-12-31 |
Training of R. Townsend
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LEXEO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
- Stock Market
- Insiders
- R. Townsend
